Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the period ending January 17, 2023. The document serves as a response to an inquiry from B3 S.A. - Brasil, Bolsa, Balcão regarding recent price oscillations and trading volume of the company's common shares.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on market trading statistics for the period of January 3, 2023, through January 16, 2023.
| Date | Opening Price (R$) | Closing Price (R$) | Volume (R$) | Shares Traded |
|---|---|---|---|---|
| 01/03/2023 | 14.16 | 14.17 | 518,560,034.00 | 36,363,800 |
| 01/11/2023 | 14.51 | 14.29 | 1,056,451,305.00 | 74,419,600 |
| 01/16/2023 | 13.72 | 13.24 | 718,519,767.00 | 53,702,200 |
Material Changes
The filing highlights significant volatility in the company's share price during the first half of January 2023. Notable movements include:
- A peak closing price of R$ 14.54 on January 10, 2023.
- A sharp decline on January 16, 2023, with the share price dropping 4.61% to close at R$ 13.24.
- Trading volume surged to over R$ 1.05 billion on January 11, 2023.
Management Commentary and Risks
In response to the regulatory inquiry, Ambev S.A. stated it is not aware of any material fact or act not already of public knowledge that would justify the recent price oscillations. The company reiterated its commitment under CVM Resolution 44/21 to disclose any material facts that could significantly influence security prices or investor decisions. No specific risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify if there are any undisclosed material events or rumors driving the 4.61% price drop on January 16, 2023.
- Review the company's most recent Form 20-F or quarterly reports for underlying financial health, as this filing contains no operational metrics.
- Monitor subsequent filings for any updates regarding the trading volatility observed in early January 2023.